Cover Image

Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China

ABSTRACTDTaP-HBV-IPV-Hib hexavalent vaccine has been used in high-income countries for many years to prevent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and invasive Haemophilus influenzae type b disease. Currently, no hexavalent vaccines have been approved for use in China. Evidence...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aodi Huang (Author), Xia Xu (Author), Lin Tang (Author), Lifang Huang (Author), Jun Li (Author), Xue Zhang (Author), Jiajie Liu (Author), Yang Zhou (Author), Bingling Zhang (Author), Lei Wang (Author), Qian Zhang (Author), Zemei Zhou (Author), Yu Wang (Author), Xiaoqi Wang (Author), Qianqian Liu (Author), Siyu Liu (Author), Zundong Yin (Author), Fuzhen Wang (Author)
Format:	Book
Published:	Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016)
by: Andrea Guerra, et al.
Published: (2024)

DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
by: Andrew W. Lee, et al.
Published: (2017)

Rejoinder to comments on ''Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: A cross-sectional survey in China''
by: Floriano Amimo
Published: (2024)

A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
by: Andrew Dakin, et al.
Published: (2023)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019)

DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure
by: Florence Boisnard, et al.
Published: (2023)

Adverse events following immunization of co- and separate administration of DTaP-IPV/Hib vaccines: A real-world comparative study
by: Yiqing Zhu, et al.
Published: (2024)

Safety and immunogenicity of a fully-liquid DTaP-IPV-Hib-HepB vaccine (Vaxelis™) in premature infants
by: Marissa B. Wilck, et al.
Published: (2021)

Immunogenicity and safety of DTaP/Hib combined vaccination at different inoculation sites among infants
by: Zhen-jiang LIU, et al.
Published: (2022)

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously
by: Anitta Ahonen, et al.
Published: (2022)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
by: Marina George, et al.
Published: (2023)

Long-term antibody persistence against hepatitis B in adolescents 14-15-years of age vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy
by: Tino F. Schwarz, et al.
Published: (2019)

Immunogenicity and safety of a DTaP-IPV//PRP~T combination vaccine given with hepatitis B vaccine: a randomized open-label trial
by: Maria Rosario Capeding, et al.
Published: (2008)

Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib in Indian infants
by: Sanjay K. Lalwani, et al.
Published: (2017)

A prospective, observational, multi-center, post-marketing safety surveillance study of the GSK combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b invasive infections (DTaP-IPV/Hib) in South Korean infants
by: Diego Mpia Elenge, et al.
Published: (2024)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
by: Soon Min Lee, et al.
Published: (2019)

Safety and immunogenicity of a combined DTacP-sIPV-Hib vaccine in animal models
by: Yuntao Zhang, et al.
Published: (2022)

Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa
by: Timo Vesikari, et al.
Published: (2017)

Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019-2022
by: Qinghua Chen, et al.
Published: (2024)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine
by: Julianne Bayliss, et al.
Published: (2021)

Improving childhood vaccination coverage rates: the case of fourth dose of DTaP
by: Sarah J. Clark, et al.
Published: (2020)

Proactive surveillance on DTaP vaccination-induced adverse local reac-tions among infants in a county of Jiangsu province
by: Peng ZHANG, et al.
Published: (2024)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
by: Yoshiyuki Tanaka, et al.
Published: (2017)

Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
by: Pope Kosalaraksa, et al.
Published: (2018)

A DTAP-IPV//PRP~T VACCINE: A REVIEW OF 16 YEARS' CLINICAL EXPERIENCE
by: Stanley A. Plotkin, et al.
Published: (2012)

Innovation of Shallot (Allium Ascalonicum L) Essential Oil for Fever Reduction in Infants Post DTaP Immunization
by: Setiawandari Setiawandari, et al.
Published: (2021)

Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature
by: Meichen Pan, et al.
Published: (2023)

A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months
by: Hitt Sharma, et al.
Published: (2022)

New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020Research in context
by: Zheng Hui, et al.
Published: (2024)

Reply to "Financial hindrances to introducing higher-valent pediatric combination vaccines"
by: Aodi Huang, et al.
Published: (2024)

A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration
by: The MMR-158 Study Group
Published: (2019)

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
by: Min You, et al.
Published: (2023)

Do Pentavalent (DTwP-Hib-HBV) vaccines have sex-differential nonspecific effects? An observational study
by: Thomas Aamand, et al.
Published: (2023)

Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study
by: Miaolei Li, et al.
Published: (2021)

Chronic occupational exposure to hexavalent chromium causes DNA damage in electroplating workers
by: Ren Xiao-Bin, et al.
Published: (2011)

Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants
by: Yanping Li, et al.
Published: (2017)

Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains
by: Wei Cai, et al.
Published: (2020)

Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure
by: Lili Zhang, et al.
Published: (2022)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
by: Ki Hwan Kim, et al.
Published: (2019)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
by: Wenhui Wang, et al.
Published: (2022)